Diametric Capital’s Wave Life Sciences WVE Stock Holding History

Diametric Capital’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,011	Closed	-$108K	–	475
2023 Q1	$108K	Buy	+25,011	New	+$115K	0.05%	262

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Diametric Capital's WVE Position: Q2 2023 in Review

Diametric Capital sold out of Wave Life Sciences (WVE) in Q2 2023, closing a stake of 25,011 shares — an estimated $108K sold.

Diametric Capital first reported a position in WVE in Q1 2023 and held it in 1 quarter. The position peaked at $108K in Q1 2023. 81 funds tracked by Wall St. Rank hold WVE as of Q2 2023.

Diametric Capital reported no remaining Wave Life Sciences position as of Q2 2023 after selling out during the quarter.
Diametric Capital sold 25,011 Wave Life Sciences shares in Q2 2023, an estimated $108K.
Diametric Capital first reported a position in Wave Life Sciences in Q1 2023 and held it in 1 quarter.
Diametric Capital's Wave Life Sciences position peaked at $108K in Q1 2023.
81 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2023.

Based on Diametric Capital's 13F filing for Q2 2023, filed 11 Aug 2023.